Literature DB >> 15948244

Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100).

Banchob Sripa1, Saman Leungwattanawanit, Takayuki Nitta, Chaisiri Wongkham, Vajarabhongsa Bhudhisawasdi, Anucha Puapairoj, Chongrak Sripa, Masanao Miwa.   

Abstract

AIM: To establish and characterize a new cholangiocarcinoma cell line from a patient living in the Opisthorchis viverrini (O. viverrini) endemic area of Northeast Thailand.
METHODS: Fresh liver biopsy and bile specimens were obtained from a 65-year-old Thai woman with cholangiocarcinoma of the porta hepatis. After digestion, the cells were cultured in Ham's F12 media. The established cell line was then characterized for growth kinetics, cell morphology, imm-unocytochemistry and cytogenetics. Tumorigenicity of the cell line was determined by heterotransplanting in nude mice.
RESULTS: The primary tumor was a poorly differentiated tubular adenocarcinoma. Examination of the bile revealed malignant cells with O. viverrini eggs. The cholangioc-arcinoma cell line KKU-100 was established 4 mo after the primary culture-population doubling time was 72 h. KKU-100 possesses compact and polygonal-shaped epithelial cells. Immunocytochemically, this cell line exhibited cytokeratin, EMA, CEA, and CA125, but not alpha-fetoprotein (AFP), CA19-9, desmin, c-met, or p53. Such protein expressions parallel those of the primary tumor. Cytogenetic analysis identified aneuploidy karyotypes with a modal chromosome number of 78 and marked chromosomal structural changes. Inoculation of KKU-100 cells into nude mice produced a transplantable, poorly differentiated aden-ocarcinoma, similar to the original tumor.
CONCLUSION: KKU-100 is the first egg-proven, Opisthorchis-associated cholangiocarcinoma cell line, which should prove useful for further investigations of the tumor biology of this cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15948244      PMCID: PMC4315993          DOI: 10.3748/wjg.v11.i22.3392

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Opisthorchiasis control in Thailand.

Authors:  P Jongsuksuntigul; T Imsomboon
Journal:  Acta Trop       Date:  2003-11       Impact factor: 3.112

2.  Chromosomal breakpoints in cholangiocarcinoma cell lines.

Authors:  P D Storto; S L Saidman; A J Demetris; E Letessier; T L Whiteside; S M Gollin
Journal:  Genes Chromosomes Cancer       Date:  1990-11       Impact factor: 5.006

3.  Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer.

Authors:  S Sirisinha; T Tengchaisri; S Boonpucknavig; N Prempracha; S Ratanarapee; A Pausawasdi
Journal:  Asian Pac J Allergy Immunol       Date:  1991-12       Impact factor: 2.310

4.  A histopathologic study of 61 cases of peripheral intrahepatic cholangiocarcinoma.

Authors:  P Sinawat; V Hemsrichart
Journal:  J Med Assoc Thai       Date:  1991-10

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Establishment and characterization of the human cholangiocarcinoma cell line HChol-Y1 in a serum-free, chemically defined medium.

Authors:  N Yamaguchi; H Morioka; H Ohkura; S Hirohashi; K Kawai
Journal:  J Natl Cancer Inst       Date:  1985-07       Impact factor: 13.506

7.  A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium.

Authors:  M Miyagiwa; T Ichida; T Tokiwa; J Sato; H Sasaki
Journal:  In Vitro Cell Dev Biol       Date:  1989-06

8.  Biliary adenocarcinoma. Characterisation of three new human tumor cell lines.

Authors:  A Knuth; H Gabbert; W Dippold; O Klein; W Sachsse; D Bitter-Suermann; W Prellwitz; K H Meyer zum Büschenfelde
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

9.  Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

Authors:  Y Shimizu; A J Demetris; S M Gollin; P D Storto; H M Bedford; S Altarac; S Iwatsuki; R B Herberman; T L Whiteside
Journal:  Int J Cancer       Date:  1992-09-09       Impact factor: 7.396

10.  Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area.

Authors:  P D Sturm; I O Baas; M J Clement; A Nakeeb; G Johan; A Offerhaus; R H Hruban; H A Pitt
Journal:  Int J Cancer       Date:  1998-12-09       Impact factor: 7.396

View more
  80 in total

1.  Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines.

Authors:  Chariya Hahnvajanawong; Wongwarut Boonyanugomol; Tapanawan Nasomyon; Watcharin Loilome; Nisana Namwat; Natthinee Anantachoke; Wichittra Tassaneeyakul; Banchob Sripa; Wises Namwat; Vichai Reutrakul
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Role of cagA-positive Helicobacter pylori on cell proliferation, apoptosis, and inflammation in biliary cells.

Authors:  Wongwarut Boonyanugomol; Chariya Chomvarin; Seung-Chul Baik; Jea-Young Song; Chariya Hahnvajanawong; Kyung-Mi Kim; Myung-Je Cho; Woo-Kon Lee; Hyung-Lyun Kang; Kwang-Ho Rhee; Banchob Sripa
Journal:  Dig Dis Sci       Date:  2010-12-22       Impact factor: 3.199

3.  Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.

Authors:  Apaporn Menakongka; Tuangporn Suthiphongchai
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

4.  Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.

Authors:  Ponlapat Yonglitthipagon; Chawalit Pairojkul; Yaovalux Chamgramol; Alex Loukas; Jason Mulvenna; Jeffrey Bethony; Vajarabhongsa Bhudhisawasdi; Banchob Sripa
Journal:  Hum Pathol       Date:  2012-03-24       Impact factor: 3.466

5.  Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma.

Authors:  Ubonrat Thamrongwaranggoon; Sakkarn Sangkhamanon; Wunchana Seubwai; Paksiree Saranaruk; Ubon Cha'on; Sopit Wongkham
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

6.  Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in vitro.

Authors:  Taweewun Hunsawong; Ekapot Singsuksawat; Nuannapa In-chon; Watinee Chawengrattanachot; Chanitra Thuwajit; Banchob Sripa; Anucha Paupairoj; Siri Chau-in; Peti Thuwajit
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-03       Impact factor: 4.553

7.  Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.

Authors:  Benjaporn Buranrat; Auemduan Prawan; Upa Kukongviriyapan; Sarinya Kongpetch; Veerapol Kukongviriyapan
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

8.  Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Zhiliang Wu; Watcharin Loilome; Paiboon Sithithaworn; Isao Nagano; Somchai Pinlaor; Puangrat Yongvanit; Phuangphaka Sadee Nielsen; Chawalit Pairojkul; Narong Khuntikeo
Journal:  Tumour Biol       Date:  2012-06-26

9.  Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient.

Authors:  Panthip Rattanasinganchan; Kawin Leelawat; Sa-ard Treepongkaruna; Chintana Tocharoentanaphol; Somboon Subwongcharoen; Tuangporn Suthiphongchai; Rutaiwan Tohtong
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

10.  A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells.

Authors:  Michael J Smout; Thewarach Laha; Jason Mulvenna; Banchob Sripa; Sutas Suttiprapa; Alun Jones; Paul J Brindley; Alex Loukas
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.